These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 18753255)
1. FGFR3 and FGFR4 do not mediate renal effects of FGF23. Liu S; Vierthaler L; Tang W; Zhou J; Quarles LD J Am Soc Nephrol; 2008 Dec; 19(12):2342-50. PubMed ID: 18753255 [TBL] [Abstract][Full Text] [Related]
2. Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype. Li H; Martin A; David V; Quarles LD Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E508-17. PubMed ID: 21139072 [TBL] [Abstract][Full Text] [Related]
3. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4. Gattineni J; Alphonse P; Zhang Q; Mathews N; Bates CM; Baum M Am J Physiol Renal Physiol; 2014 Feb; 306(3):F351-8. PubMed ID: 24259513 [TBL] [Abstract][Full Text] [Related]
4. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Gattineni J; Bates C; Twombley K; Dwarakanath V; Robinson ML; Goetz R; Mohammadi M; Baum M Am J Physiol Renal Physiol; 2009 Aug; 297(2):F282-91. PubMed ID: 19515808 [TBL] [Abstract][Full Text] [Related]
5. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. Gattineni J; Twombley K; Goetz R; Mohammadi M; Baum M Am J Physiol Renal Physiol; 2011 Aug; 301(2):F371-7. PubMed ID: 21561999 [TBL] [Abstract][Full Text] [Related]
6. FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice. Han X; Cai C; Xiao Z; Quarles LD J Mol Cell Cardiol; 2020 Jan; 138():66-74. PubMed ID: 31758962 [TBL] [Abstract][Full Text] [Related]
9. FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice. Du E; Xiao L; Hurley MM J Cell Physiol; 2017 Mar; 232(3):610-616. PubMed ID: 27306296 [TBL] [Abstract][Full Text] [Related]
10. Osteocyte-specific deletion of Fgfr1 suppresses FGF23. Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D and type II sodium-dependent phosphate cotransporters. Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552 [TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice. Martins JS; Liu ES; Sneddon WB; Friedman PA; Demay MB Endocrinology; 2019 Oct; 160(10):2204-2214. PubMed ID: 31237611 [TBL] [Abstract][Full Text] [Related]
13. Characterization of FGF23-Dependent Egr-1 Cistrome in the Mouse Renal Proximal Tubule. Portale AA; Zhang MY; David V; Martin A; Jiao Y; Gu W; Perwad F PLoS One; 2015; 10(11):e0142924. PubMed ID: 26588476 [TBL] [Abstract][Full Text] [Related]
14. Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO. Xiao L; Naganawa T; Lorenzo J; Carpenter TO; Coffin JD; Hurley MM J Biol Chem; 2010 Jan; 285(4):2834-46. PubMed ID: 19933269 [TBL] [Abstract][Full Text] [Related]
15. Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation. Farrow EG; Summers LJ; Schiavi SC; McCormick JA; Ellison DH; White KE J Endocrinol; 2010 Oct; 207(1):67-75. PubMed ID: 20675303 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. Nakatani T; Ohnishi M; Razzaque MS FASEB J; 2009 Nov; 23(11):3702-11. PubMed ID: 19584304 [TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism. Olauson H; Lindberg K; Amin R; Jia T; Wernerson A; Andersson G; Larsson TE J Am Soc Nephrol; 2012 Oct; 23(10):1641-51. PubMed ID: 22878961 [TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids Decrease Longitudinal Bone Growth in Pediatric Kidney Transplant Recipients by Stimulating the FGF23/FGFR3 Signaling Pathway. Delucchi Á; Toro L; Alzamora R; Barrientos V; González M; Andaur R; León P; Villanueva F; Galindo M; Las Heras F; Montecino M; Moena D; Lazcano A; Pinto V; Salas P; Reyes ML; Mericq V; Michea L J Bone Miner Res; 2019 Oct; 34(10):1851-1861. PubMed ID: 31099911 [TBL] [Abstract][Full Text] [Related]
19. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice. Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636 [TBL] [Abstract][Full Text] [Related]
20. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats. Leifheit-Nestler M; Grabner A; Hermann L; Richter B; Schmitz K; Fischer DC; Yanucil C; Faul C; Haffner D Nephrol Dial Transplant; 2017 Sep; 32(9):1493-1503. PubMed ID: 28339837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]